INTRODUCTION
T opical corticosteroids (TCs) are a group of drugs which form the backbone of topical therapy in skin diseases due to their anti-inflammatory, vasoconstrictive, and anti-proliferative functions. Their efficacy and safety are determined by their potencies. They are widely prescribed by dermatologists, general physicians as well as by physicians of other specialities, notably pediatricians. [1] Wide usage and misuse at various levels and easy over-the-counter availability has led to the commonly seen phenomenon of topical steroid addiction. Finally, however, TC phobia (TCP), which is located at the other end of the spectrum of topical steroid abuse, is being quite frequently reported worldwide. [2] 
TOPICAL CORTICOPHOBIA
A phobia is an irrational fear of something that leads to an extreme aversion and deliberate avoidance of it. This may sometimes reach such an extent that it causes gross socio-occupational dysfunction. [3] Topical corticophobia among parents and caregivers of atopic children that the adverse effects of systemic steroids also holds good in all cases of topical steroid use. In fact, topical steroid abuse is one of the main causes of the recent evolution of TCP, and the fear of indiscriminate use often deters the doctor from prescribing it where it is needed. [3] Though TCs have been in use since 1952, the phenomenon of TCP among doctors and patients was first reported from Germany as late as in the year 2000. [6] It is most often encountered in chronic inflammatory dermatoses where TCs may be required for a prolonged period. Hence, most of the studies of TCP have been carried out in patients and caregivers of atopic dermatitis (AD). Charman et al. published the first paper on TCP in AD. The first study on TCP published by Charman et al. was based on a questionnaire to which answers were provided by 200 patients of AD or their caregivers. Of them, 72% worried about using TCs on their own or their child's skin and 24% admitted that they were noncompliant with the therapy because of this. The main concerns voiced were skin thinning and systemic absorption leading to growth retardation. [6] In a similar but more recent study, 38.3% of the caregivers did not wish to use TCs on their children's skin. [7] These observers reported that epidemiologically TCP occurred more commonly in the female sex. Paternal history of AD and frequent change of clinics were the other factors associated with steroid phobia. However, there was no correlation with severity of AD. [7] A study from China found that even in moderate to severe eczema, 50% of the caregivers requested nonsteroid prescriptions. [8] Unfortunately, a thorough online search did not reveal any study on topical corticophobia from India.
THE CONSEQUENCES
The results of TCP can be disastrous as it leads to a definite inadequacy in the therapy. There may be various stages of denial on the part of the patient -from usage in inappropriate doses to total refusal to apply the drug. Patients may refuse to apply the medication, may apply it haphazardly or in inadequate amounts and frequency. [3] To avoid using TCs, many caregivers look for alternative and indigenous forms of medications. Chinese medications and herbs are one such form of treatment. Paradoxically some of these medications have been found to contain TCs, and they are prescribed by the alternative medicine practitioners without the patients' knowledge. [9] TCP is a rapidly growing phenomenon fanned by misinformation, ignorance, and improper counseling and advice. The pharmaceutical industry, the press and electronic media as well as laymen are playing a significant role in the spread of this unfortunate psychological ailment. [2] Hence, management at various levels is necessary to control the rapid growth of TCP. [6] MANAGEMENT Though TCs are categorized into different classes according to their potency, the patients or their parents and caregivers of atopic children who are the end-point users, are not aware of the differences in the quality of different TCs and their ability to produce side-effects. Neither are they aware of the differences between systemic and TCs. Hence, from the layman's viewpoint, all forms of steroids are clubbed together under one head. To avoid this confusion and its psychological consequences it has been proposed that the labels on the packets and tubes of TCs should clearly identify the potency and side effects of the various classes of the drug. The labeling should be such as to clearly emphasize the lesser risk of low to moderately potent TCs and the importance of applying sufficient medication to achieve a satisfactory clinical response. Such a labeling may go a long way in removing fears about the side-effects of most of the TCs and reinforce the counseling by doctors. [5] Misconceptions about the harmful effects of TCs are often spread by pharmacists because of their lack of awareness. This may lead to a lack of faith on the beneficial effects of TC. Consequently, there is a tendency to convey some wrong information regarding potency and usage of the drug and pass on their mistrust to the patients. [10] Counseling of pharmacists by dermatologists, may help in removal of misconceptions and a change of attitude on the part of pharmacists and thus prevent them from fanning a fear of TCs among laymen. [11] Similarly, there is a negative awareness about the benefits and side-effects of corticosteroids among many nondermatologist doctors including general practitioners. [12] General practitioners and pediatricians frequently treat AD patients many of whom trust them solely for health-related advice. Hence, better education and counseling of general practitioners regarding the safety of TCs is necessary to dispel wrong notions about the drug. [6] The role of the dermatologist and the pediatrician in the management and control of TCP cannot be overemphasized. However, TCP plays a strong role as an impediment to effective treatment of AD with TCs. For effective therapy, a strong effort is required to allay fears regarding TCs. For this to happen, a strong patient/caregiver-doctor relationship needs to be built so that the parent of an AD patient sitting across the table may trust and believe what the doctor is communicating to them. The nature of the disease, its severity and the reasons for which TC application are necessary should be explained to the parent in no uncertain terms. A brief explanation about the nature of TCs, their benefits, potencies, and side-effects helps the parents to understand the medicine being prescribed and will also from a shield against whatever misinformation that may garnered later on from laymen, social media, and internet. This should be followed by lucid oral and written instructions regarding the amount of drug (including Finger tip unit [FTU]) to be applied, the mode of application and duration of application. It should be emphasized that side-effects usually occur only if these instructions are not followed. Finally, effective follow-up at reasonable intervals helps to reassure the child as well as the parent regarding the safe use of the drug. [13] Hence, for effective control of TCP and patient compliance a strong doctor-patient relationship and excellent and skillful communication regarding safety of TC by the dermatologist is an absolute necessity. [2] CONCLUSION TCs have been used extensively for more than 60 years. In a large section of the population, the TCs have been overused, misused, and abused extensively leading to both systemic and local side-effects. [14] [15] [16] This catastrophe could have been avoided had the TCs been used ethically. [17] TCP, a relatively recent phenomenon has developed due to various misconceptions based on wrong information regarding the side effects of TC. Improper labeling of tubes by pharmaceuticals, sale of drugs without proper prescriptions by salesmen at pharmacies and misinformation spread by print and electronic medium as well as by ignorant laymen -all contribute to the development of this phobia. Parents and caregivers of atopic children are alarmed when the TCs are prescribed by dermatologists. [18] They either try to force the dermatologist to change the prescription or avoid using it altogether. The consequences can be disastrous as enumerated earlier. Hence, parents and caregivers of atopic children must be patiently counseled about the utility, based on potency, age, and site of application, duration of usage and method of usage of the TC prescribed. [5] Financial Support and Sponsorship Nil.
